# Genvec

**Canonical:** https://apis.io/providers/genvec/  
**APIs profiled:** 0

GenVec was a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Gaithersburg, Maryland, that pioneered adenovector (AdenoVerse) gene-delivery technology to develop gene-based therapeutics and vaccines, including programs for hearing loss and balance disorders. Backed by Canaan Partners, ARCH Venture Partners, EDF Ventures and HealthCare Ventures, GenVec was acquired by Precigen (formerly Intrexon) on June 16, 2017 and no longer operates as an independent company. It has no public developer platform, API, or documentation surface; the genvec.com domain no longer resolves.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biopharmaceutical, Gene Therapy, Vaccines, Biotechnology, Gene Delivery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/genvec/). Scores are computed from the provider's own public artifacts under a published rubric.